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Abstract
Background
There is an urgent need to identify tools able to provide reliable information on the cause of
death in low-income regions, since current methods (verbal autopsy, clinical records, and
complete autopsies) are either inaccurate, not feasible, or poorly accepted. We aimed to
compare the performance of a standardized minimally invasive autopsy (MIA) approach
with that of the gold standard, the complete diagnostic autopsy (CDA), in a series of adults
who died at Maputo Central Hospital in Mozambique.
Methods and Findings
In this observational study, coupled MIAs and CDAs were performed in 112 deceased
patients. The MIA analyses were done blindly, without knowledge of the clinical data or the
results of the CDA. We compared the MIA diagnosis with the CDA diagnosis of cause of
death.
CDA diagnoses comprised infectious diseases (80; 71.4%), malignant tumors (16;
14.3%), and other diseases, including non-infectious cardiovascular, gastrointestinal, kid-
ney, and lung diseases (16; 14.3%). A MIA diagnosis was obtained in 100/112 (89.2%)
cases. The overall concordance between the MIA diagnosis and CDA diagnosis was
75.9% (85/112). The concordance was higher for infectious diseases and malignant tumors
(63/80 [78.8%] and 13/16 [81.3%], respectively) than for other diseases (9/16; 56.2%). The
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specific microorganisms causing death were identified in the MIA in 62/74 (83.8%) of the
infectious disease deaths with a recognized cause.
The main limitation of the analysis is that both the MIA and the CDA include some
degree of expert subjective interpretation.
Conclusions
A simple MIA procedure can identify the cause of death in many adult deaths in Mozam-
bique. This tool could have a major role in improving the understanding and surveillance of
causes of death in areas where infectious diseases are a common cause of mortality.
Author Summary
Why Was This Study Done?
• While complete autopsies are considered the gold standard for the determination of
cause of death, they are poorly accepted and difficult to perform in middle- and low-
income countries. More feasible options, such as verbal autopsies and clinical records,
are highly inaccurate.
• Minimally invasive autopsy techniques have been proposed as a more acceptable alter-
native to complete autopsy, and the results of these techniques have been shown to be
relatively accurate; however, current minimally invasive autopsy protocols generally
involve high-tech imaging procedures not available in middle- and low-income settings.
• Our study was designed to develop a simplifiedminimally invasive autopsy method that
would be feasible in middle- and low-income countries, and to validate this method
against the gold standard.
What Did the Researchers Do and Find?
• The minimally invasive autopsy developed in this study consists of the collection of
blood and cerebrospinal fluid samples and the collection of tissue samples from solid
organs using biopsy needles, followed by histological and microbiological analyses.
• Coupledminimally invasive and complete autopsies were performed in 112 deceased
patients. The samples obtained by both techniques were evaluated independently.
• Concordance between the putative diagnosis obtained with the minimally invasive
autopsy and the gold standard diagnosis obtained by complete autopsy was 75.9%.
• The agreement was particularly high for infectious diseases.Moreover, the specific
microorganisms causing death were accurately identified in the minimally invasive
autopsy samples.
Validity of Minimally Invasive Autopsy in Cause of Death Assessment
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What Do These Findings Mean?
• Minimally invasive autopsy is a reliable tool that can improve our understanding of the
causes of death in Mozambique, where infectious diseases are a common cause of
mortality.
• The use of this tool could improve health planning and priority setting for the most vul-
nerable populations in the world.
Introduction
Current estimates of major causes of mortality in middle- and low-income countries are ham-
pered by the lack of direct and reliable data. Complete diagnostic autopsy (CDA), the gold
standard method to determine the cause of death [1], is seldom performed in these countries
due to limited human resources and cultural and/or religious backgrounds that negatively
influence acceptance and consent in some regions [2,3]. In addition, many deaths occur outside
the health system, which precludes not only postmortem evaluation but also frequently the
basic medical assistance that allows certificationof the death event. Verbal autopsy is a struc-
tured interview administered to relatives of the deceased individual and is currently recom-
mended by WHO as an alternative to CDA to overcome this problem in low- and middle-
income countries [4–7]. However, although verbal autopsy provides a broad syndromic
approach, its performance for etiological diagnosis is very limited, and it tends to misclassify a
substantial number of deaths [1]. Finally, clinical records generally show a high rate (10%–
30%) of discordance with the results of CDAs [8,9], and this discordance further increases in
resource-constrained settings, where the availability of ancillary diagnostic tests such as imag-
ing or microbiological exams is scarce or suboptimal [10,11].
We hypothesized that a simple minimally invasive postmortem sampling procedure could
provide reliable etiological information for cause of death investigation and potentially replace
other more invasive and less acceptable methods. Recently, we reported the methodologyof a
standardizedminimally invasive autopsy (MIA) [12,13]. This technique involves organ-
directed sampling using biopsy needles and provides key fluids and tissue material for histolog-
ical and microbiological analyses. The procedure is simple and could be easily conducted by
trained technicians. In this study, we aimed to analyze the validity of the MIA to determine the
cause of death in a series of in-hospital adult deaths in Mozambique, by comparing the MIA
diagnosis with the gold standard CDA diagnosis obtained by the same group of experts.
Methods
Study Setting and Design
This study received the approval of the following regulatory bodies: the Internal Scientific
Committee of the Barcelona Centre for International Health Research (Spain; approved, 6 Sep-
tember 2012), Clinical Research Ethics Committee of the Hospital Clinic of Barcelona (Spain;
approved, File 2013/8677), Internal Scientific Committee of the Centro de Investigação em
Saúde de Manhiça (Mozambique; approved, Ref. CCI/31/Fev 2013), the Serviceof Pathology of
Maputo Central Hospital (Mozambique; approved, 5 August 2013), and the National Bioethics
Committee of Mozambique (Mozambique; approved, Ref. 342/CNBS/13).
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This observational study was carried out at the Department of Pathology of the Maputo
Central Hospital, a 1,500-bed government-funded quaternary health care center. From
November 2013 to March 2015, we conducted up to two coupledMIAs and CDAs per day
when cases fulfilled the inclusion criteria. All the patients included in this analysis fulfilled the
following criteria: (1) a CDA requested by the clinician as part of the medical evaluation of the
patient and (2) informed consent to perform the autopsy given by the relatives. The following
exclusion criterion was established: death of traumatic origin. The current paper will present
the analyses for adults (patients older than 15 y) excluding maternal deaths. In order to select
only two cases per day from among the daily CDA requests received at the department
(between 5 and 12 per day) without introducing selection biases, the two patients with death
recorded before and closest to the time of 8:00 A.M. were included in the study.
In all cases, informed consent to perform the autopsy was obtained from the relatives of the
deceasedpatients. The STROBE checklist and the prospective analysis plan are included as S1
Text and S2 Text, respectively.
Autopsy Procedures
The autopsy procedure was performed by a pathologist assisted by a technician. The detailed
MIA pathological and microbiologicalmethods have been reported elsewhere [12,13]. In brief,
the procedure includes disinfection of the surface of the body, collection of 20 ml each of blood
and cerebrospinal fluid (CSF), and puncture of solid organs (liver, lungs, bone marrow, and
central nervous system [CNS]) using biopsy needles (14G–16G) to collect samples for microbi-
ological and histological analysis. In addition, the heart, spleen, and kidneys were sampled for
histological analysis only.
Immediately after the MIA, the CDA procedure was conducted by a second pathologist not
involved with the MIA. The CDA was completed in all cases within 1 h after completion of the
MIA. Briefly, a dissectionwas performedwith macroscopic evaluation of all the organs follow-
ing a standardizedmacroscopic protocol [14]. In this procedure, samples from the same viscera
sampled in the MIA and from any grossly identified lesions were collected for histological and
microbiological analysis. The microbiological results of the blood and CSF were also included
in the CDA evaluation.
In all cases, both the MIA and the CDA were performedwithin 24 h after death.
Histological and Microbiological Analyses
All paraffin blocks and the microbiological samples were sent to the central lab (Hospital Clinic
of Barcelona), where two pathologists and a microbiologist, who were not aware of any clinical
information or the findings of the CDA, analyzed the histological slides and the microbiolog-
ical samples from the MIA. After a washout period (minimum 3 mo, range 3–6 mo), the same
experts evaluated the slides and microbiological samples obtained at the CDA, while blinded to
the findings of the MIA.
All samples collected for histology were routinely stained with hematoxylin and eosin.
Ancillary histochemical (e.g., Ziehl-Neelsen) and/or immunohistochemical stains (e.g.,Toxo-
plasma gondii) were used, if required, to achieve the diagnosis. The microbiological analyses
have been reported in detail [13]. In brief, universal screening was performed for all cases,
which included detection of Plasmodium falciparum by PCR, detection of antibodies against
HIV-1/2, and bacterial/fungal cultures of blood, CSF, liver, lungs, and CNS. In samples positive
for antibodies against HIV, the viral load was determined.We routinely applied an additional
microbiological screening in all HIV-positive cases, which included real-time PCR in CSF and
CNS samples for T. gondii,Mycobacterium tuberculosis, and Cryptococcus spp. and real-time
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PCR in lung samples for Pneumocystis jirovecii, Cryptococcus spp., andM. tuberculosis. Other
microorganisms were also tested depending on the pathological findings observed in the MIA-
obtained tissues.
The samples from the CDAs were analyzed following the same strategy used for the analysis
of the MIA samples. The team was aware of all the findings of the CDA (macroscopic, histolog-
ical, and microbiological results) and of the clinical information.
All the histological and microbiological analyses were performed at the central laboratory in
Barcelona, except for blood, CSF, and tissue cultures and HIV analyses, which were done
locally (Maputo and Manhiça).
Two scales were developed to grade the strength of the evidence of the autopsy findings, one
based on the severity of the pathological findings and the other on the distribution and type of
the microorganisms identified (Table 1).
Determination of the Cause of Death
Once all the analysis of the MIA samples had been completed, a panel composed of a patholo-
gist, a microbiologist, and a clinician with expertise in infectious diseases and epidemiology
evaluated all the data of the MIA and assigned the MIA diagnosis, i.e., the disease or condition
putatively leading to death. No clinical information was used for the MIA diagnosis assign-
ment. After a washout period (minimum 3 mo, range 3–6 mo), the same panel evaluated the
data from the CDA and the clinical records, and assigned the final diagnosis of cause of death
(CDA diagnosis). All morbid conditions directly leading to death, any underlying conditions
(if present), as well as any other significant conditions possibly contributing to death were codi-
fied following ICD-10 (International Classification of Diseases and Related Health Problems
10th Revision) [15]. This codification process was conducted independently for the MIA and
CDA diagnoses. To assess the reproducibility of the coding guidelines and the ICD-10 codifica-
tion, a random sample of 15 CDAs were blindly coded by a second investigator who was not
involved in the initial assignment of codes.
Table 1. Strength of the evidence of the autopsy findings identified in the complete diagnostic autopsy and the minimally invasive autopsy.
Level Evidence Pathological Findingsa Microbiological Findings
0 None No pathological findings or nonspecific
changes
No microorganisms identified
1 Slight Mild pathological findings, unlikely to be the
cause of death
Microorganisms that are frequent contaminants
2 Fair Mild pathological findings, possibly causing
deathb
Microorganisms that can either represent true pathogens or colonizing/contaminants;
mixed infectionsc
3 Moderate Pathological findings of moderate intensity,
probably causing deathb
Microorganisms that can either represent true pathogens or colonizing/contaminants
detected by both molecular and culture-based methods
4 Strong Severe pathological findings likely to be the
cause of death
Microorganisms that represent true pathogens and/or microorganisms consistently
detected in4 samples
Microbiology examples according to strength of evidence classification: (1) coagulase-negative staphylococci, group viridans streptococci; (2 and 3)
enterobacteriaceae such as Klebsiella pneumoniae or Escherichia coli, non-fermentative Gram-negative bacilli; (4) Cryptococcus spp., T. gondii, M.
tuberculosis, P. jirovecii, Legionella pneumophila.
aPathological findings include only microscopic changes in the minimally invasive autopsy and both macro- and microscopic changes in the complete
diagnostic autopsy.
bThe finding in the histological (histochemistry, immunohistochemistry) exam of a microorganism associated with inflammatory changes increased the
pathological score by one.
cMixed infection: multiple pathogens are detected, and it is not possible to determine which one represents the etiological cause of death.
doi:10.1371/journal.pmed.1002171.t001
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The causes of death were classified into four major groups of diseases: infectious diseases,
malignant tumors, other diseases (including non-infectious cardiovascular, gastrointestinal,
kidney, and lung diseases), and non-conclusive. When more than one severe pathological and/
or microbiological diagnosis was identified, the diseasemost likely causing death was consid-
ered the CDA diagnosis. In all cases, the direct cause of death, and not the underlying disease,
was considered as the main cause of death (e.g., miliary tuberculosis in a patient with HIV
infection or myocardial infarction in a patient with severe atherosclerosis). The same coding
system and criteria were applied to the MIA diagnoses.
Using a combination of the strength of the evidence of the histological and the microbiolog-
ical findings, a category was assigned to the certainty of the cause of death attribution of the
MIA diagnosis and the CDA diagnosis. These categories included no diagnosis and diagnosis
of low, moderate, high, and very high certainty (Table 2). In the CDA evaluation, the clinical
data were used to provide guidance and/or evidence on cause of death in cases with no diagno-
sis or with pathological/microbiological diagnoses of low or moderate certainty.
There were no differences between the planned and the final analysis of the samples per-
formed, with the exception of the scales of the strength of the evidence and the levels of diag-
nostic certainty, which were developed during the process of sample analysis. Fig 1 illustrates
the overall process and which investigators were involved at each stage.
Statistical Methods
Proportions were compared by Fisher’s exact test, and odds ratios (ORs) were calculated as a
measure of effect size whenever needed. The diagnostic efficacy of the MIA to identify the final
CDA diagnosis was evaluated as sensitivity, specificity, and positive and negative predictive val-
ues. The association between the level of certainty of the MIA diagnosis and the concordance
with the CDA diagnosis was evaluated by the Kendall tau-b rank correlation.
The concordance between the MIA and the CDA diagnosis was established by comparing
ICD-10 codes, which classify diagnoses into nested classes of different hierarchical levels. In
ICD-10, codes are organized in chapters, blocks, and three-character categories [15,16]. Thus,
a concordance was classified as complete when the ICD-10 codes were identical in chapter,
block, and three-character category [16]. Concordance was classified as partial when the codes
were within the same chapter, but there was a discrepancy either in the block or the three-char-
acter category. Finally, when the MIA and the CDA diagnoses were in different chapters, the
diagnoses were classified as discrepant.
Table 2. Level of certainty of the diagnosis of cause of death obtained by combination of the strength of the evidence of the pathological and
microbiological findings.
Pathology Microbiology
0 1 2 3 4
N Y N Y N Y N Y
0* No diagnosis* No diagnosis* No diagnosis* Low* Moderate*
1 Low Low Low Low Low Moderate Moderate Moderate Moderate
2 Low Low Low Low Moderate Moderate Moderate Moderate High
3 Moderate Moderate Moderate Moderate High High High High Very High
4 High High High High High High Very High Very High Very High
N: the microorganisms identified are rarely associated with the histological lesions observed; Y: the microorganisms identified are in concordance with the
histological lesions observed.
*When the level of evidence for the pathology findings is zero, N and Y are not applicable.
doi:10.1371/journal.pmed.1002171.t002
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The concordance between the MIA and the CDA diagnosis in terms of major groups of dis-
eases was assessed by the kappa statistic (95% confidence interval from 1,000 bootstrap replica-
tions) and was interpreted as suggested by Landis and Koch [17,18]. Statistical analysis was
performed using Stata version 14.1 (StataCorp).
The analytical plan was designedwhen the histological and microbiological results were
available. The kappa statistic was included during the peer review process.
Results
CoupledMIA and CDA procedures were performed in 112 adults (57 males and 55 females;
median age 37 y, range 16–76). The interval between death and MIA and CDA ranged between
8 and 23 h. Seventy-three out of 112 patients (65.2%) tested positive for antibodies against HIV
(all beingHIV-1). The viral load was>50,000 copies/ml in 67 out of the 73 HIV-positive
patients (91.8%).
Minimally Invasive Autopsy Diagnosis and Complete Diagnostic
Autopsy Diagnosis of Cause of Death
AMIA diagnosis of cause of death was obtained in 100 out of 112 (89.2%) cases. The level of
certainty of the MIA diagnosis was considered low in 13/100 cases, moderate in 15/100 cases,
and high or very high in 72/100 cases. A CDA diagnosis of cause of death was obtained in all
cases. The certainty of the CDA diagnosis was low in 3/112 cases, moderate in 7/112 cases, and
Fig 1. Overall study plan showing the procedures performed in the study, the investigators involved, and site
and timing of each procedure. CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
doi:10.1371/journal.pmed.1002171.g001
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high or very high in 102/112 cases. In two cases, the pathological/microbiological analyses led
to no diagnosis. In both cases, the CDA diagnosis was acute gastroenteritis with severe hydro-
electrolytic disorder based on clinical information. Infectious diseases accounted for 71.4%
(80/112) of all deaths. Patients with HIV infection diedmore frequently of infectious diseases
than HIV-negative patients (60/73, 82.1%, versus 20/39, 52.3%, OR = 4.38 [95% CI: 1.69,
11.47], p = 0.001, Fisher’s exact test). In contrast, other diseases were less frequent in HIV-posi-
tive than in HIV-negative patients (4/73, 5.5%, versus 12/39, 30.8%, OR = 0.13 [95% CI: 0.03,
0.49], p< 0.001, Fisher’s exact test).
Fig 2 shows three representative example cases of causes of death identifiedwith the MIA.
Concordance between the Minimally Invasive Autopsy Diagnosis and
the Complete Diagnostic Autopsy Diagnosis
The assignment of ICD-10 codes was identical in the 15 CDAs selected for validation. Table 3
shows the CDA diagnoses of cause of death and the concordance of the MIA diagnoses with
Fig 2. Three representative cases of cause of death identification by minimally invasive autopsy. (A–C)
Cryptococcal encephalitis: (A) Cryptococcus spp. infecting the central nervous system (hematoxylin and eosin, 200×); (B)
Cryptococcus spp. (methenamine silver stain, 200×); (C) real-time PCR positive for Cryptococcus spp. in the cerebrospinal
fluid. (D–F) Acinetobacter baumannii pneumonia: (D) A. baumannii pneumonia infecting the lung (hematoxylin and eosin,
100×); (E) A. baumannii isolated (left side of the plate) and subjected to antibiotic susceptibility testing; (F) A. baumannii
16S RNA PCR amplification from tissue samples. (G–I) Disseminated Kaposi sarcoma: (G) Kaposi sarcoma involving the
lung (hematoxylin and eosin, 100×); (H) Kaposi sarcoma involving the lung positive for human herpesvirus 8 (herpesvirus 8
antibody, 100×); (I) disseminated Kaposi sarcoma lesions in the lung (red areas on the pleural surface of the two lungs and
the trachea; macroscopic image from the complete diagnostic autopsy).
doi:10.1371/journal.pmed.1002171.g002
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Table 3. Causes of death determined by the complete diagnostic autopsy and concordance of the minimally invasive autopsy diagnosis with the
complete diagnostic autopsy diagnosis.
Cause of Death in the Complete Diagnostic Autopsy N Minimally Invasive Autopsy Diagnosis Concordance
Complete Partial
N Percent N Percent
Infectious diseases 80 61 76.3 2 2.5
Disseminated infections 41 35 85.4 0 0
Mycobacterium tuberculosis 16 15 93.8 0 0
Cryptococcus spp. 6 6 100 0 0
Mixed* 3 3 100 0 0
Toxoplasma gondii 5 5 100 0 0
Enterobacteriaceae** 6 2 33.3 0 0
No etiology identified 2 1 50.0 0 0
Other*** 3 3 100 0 0
Pulmonary infections 24 15 62.5 2 8.3
Enterobacteriaceae† 7 5 71.4 0 0
Mycobacterium tuberculosis 5 3 60.0 0 0
Pneumocystis jirovecii 2 2 100 0 0
Non-fermentative Gram-negative bacteria†† 2 1 50.0 0 0
Mixed††† 2 1 50.0 1 50.0
No etiology identified 2 2 100 0 0
Other†††† 4 1 25.0 1 25.0
Central nervous system infections 13 11 84.6 0 0
Streptococcus pneumoniae 3 3 100 0 0
Mycobacterium tuberculosis 2 1 50.0 0 0
Toxoplasma gondii 2 2 100 0 0
Other₹ 6 5 83.3 0 0
Gastrointestinal infections 2 0 0 0 0
No etiology identified 2 0 0 0 0
Malignant tumors 16 13 81.3 0 0
Hepatocellular carcinoma 5 5 100 0 0
Carcinoma of the uterine cervix 3 1 33.3 0 0
Malignant lymphoma 3 3 100 0 0
Kaposi sarcoma 2 2 100 0 0
Other tumors 3 2 66.7 0 0
Other diseases 16 3 18.8 6 37.5
Complications of cardiovascular diseases‡ 11 1 9.1 6 54.5
Lung diseases‡‡ 2 2 100 0 0
Gastrointestinal and kidney diseases‡‡‡ 3 0 0 0 0
*One case Escherichia coli + Lactobacillus sp., one case Acinetobacter sp. + Enterobacter sp., and one case Prevotella spp. + Streptococcus pneumoniae
+ human herpesvirus 1 + cytomegalovirus + Toxoplasma gondii.
**Three cases E. coli, one case Klebsiella. pneumoniae, one case Salmonella typhi, and one case Enterobacter spp.
***One case Candida glabrata, one case human herpesvirus 1, and one case Streptococcus dysgalactiae.
†Four cases K. pneumoniae, two cases E. coli, and one case Enterobacter spp.
††One case Pseudomona aeruginosa and one case Acinetobacter baumannii.
†††One case adenovirus + Cryptococcus neoformans and one case cytomegalovirus + human herpesvirus-1.
††††One case Legionella. pneumophila, one case Mycoplasma spp., one case T. gondii, and one case adenovirus.
₹One case Cryptococcus spp., one case mucormycosis, one case cytomegalovirus, one case human herpesvirus 1, one case rabies, and one case of
Prevotella spp.
‡Complications of cardiovascular diseases include five cases of cerebral infarction/hemorrhage, two cases of diabetic ketoacidosis, two cases of myocardial
infarction, one case of dilated myocardiopathy, and one case of hypertensive renal disease with renal failure.
‡‡One case of pulmonary fibrosis with pulmonary hypertension and one case of pneumoconiosis.
‡‡‡One case of acute thrombotic microangiopathy with renal necrosis, one case of alcoholic cirrhosis with upper gastrointestinal hemorrhage, and one case
of gastric ulcer with upper gastrointestinal hemorrhage.
doi:10.1371/journal.pmed.1002171.t003
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the CDA diagnoses. The MIA and CDA diagnoses were concordant in 85/112 (75.9%) cases.
Concordance was complete in 77/112 (68.8%) and partial in 8/112 (7.1%) of the cases. Concor-
dance between the MIA and CDA diagnoses was higher for infectious diseases (63/80; 78.8%)
and tumors (13/16; 81.3%) than for other diseases (9/16; 56.2%). A discrepant diagnosis was
observed in 27/112 (24.1%) of cases. Other diseases, including non-infectious cardiovascular,
gastrointestinal, kidney, and lung diseases, were the most frequently missed conditions in the
MIA (7/16; 43.7%). In the group of infectious diseases, gastrointestinal infections (2/2; 100%)
and pulmonary infections (7/24; 29.2%) were the most frequently missed conditions. In the
group of malignant tumors, carcinoma of the uterine cervixwas the most frequently missed
neoplasm (2/3; 66.6%).
Table 4 shows the sensitivity, specificity, and the positive and negative predictive values of
the MIA diagnosis for the major diagnostic categories, as well as the percentage of false-positive
and false-negative diagnoses and of cases correctly classified by the MIA. The level of certainty
of the MIA diagnosis was clearly associated with the concordance with the CDA diagnosis
(Kendall tau-b rank correlation coefficient= 0.5257, p< 0.001).
An etiological agent was identified in the CDA in 74/80 (92.5%) of the patients dying from
an infectious cause. The microorganisms identified are shown in Table 3. The same microor-
ganism was identified in theMIA in 62/74 (83.8%) patients. In four patients, the MIA diagnosis
was based only on the results of the microbiological analyses. All but one of the five hepatocel-
lular carcinomas were positive for hepatitis B virus. The fifth was negative for hepatitis B virus
and hepatitis C virus. Human papillomavirus type 16 was identified in two carcinomas of the
uterine cervix, and human papillomavirus type 35 in one case. The CDA diagnosis and the
MIA diagnosis of each case are shown in S1 Table.
Table 5 shows the correlation between the MIA diagnosis and the CDA diagnosis of all
cases, grouped according to the major disease categories. The observed agreement was 86.6%.
As the expected agreement by chance (but with probabilities equal to the overall proportions)
is 50%, the observed agreement was 73.2% (kappa = 0.732 [95% CI: 0.615, 0.838]; substantial
agreement according to the Landis and Koch classification).
Underlying Conditions and Associated Lesions/Concomitant Infections
HIV infectionwas identified as the underlying cause of death in 67 cases (59.8%). HIV infec-
tion was detected in six additional patients dying of diseases not related to HIV, and,
Table 4. Sensitivity, specificity, and positive and negative predictive values and percentage of false-positive and false-negative diagnoses and
cases correctly classified by the minimally invasive autopsy.
Cause of Death n Sensitivity Specificity Positive
Predictive Value
Negative
Predictive Value
Percent False
Positive
Percent False
Negative
Percent Correctly
Classified
Disseminated infections 41 98 (87,
100)
99 (92, 100) 98 (87, 100) 99 (92, 100) 1 (0, 8) 2 (0, 13) 98 (94, 100)
Pulmonary infections 24 79 (58, 93) 99 (94, 100) 95 (75, 100) 95 (88, 98) 1 (0, 6) 21 (7, 42) 95 (90, 99)
Central nervous system
infections
13 92 (64,
100)
100 (96,
100)
100 (74, 100) 99 (95, 100) 0 (0, 4) 8 (0, 36) 99 (95, 100)
Gastrointestinal
infections
2 0 (0, 84) 100 (97,
100)
98 (94, 100) 0 (0, 3) 100 (16, 100) 98 (94, 100)
Malignant tumors 16 81 (54, 96) 100 (96,
100)
100 (75, 100) 97 (91, 99) 0 (0, 4) 19 (4, 46) 97 (94, 100)
Other diseases 16 69 (41, 89) 98 (93, 100) 85 (55, 98) 95 (89, 98) 2 (0, 7) 31 (11, 59) 94 (89, 98)
Figures are given as percentage (95% confidence interval).
doi:10.1371/journal.pmed.1002171.t004
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consequently, HIV infection was considered an associated condition in these cases. All the
HIV infections were captured in the MIA. An underlying condition other than HIV infection
was identified in 22 cases (see S1 Table). Associated lesions not related to the sequence of
events directly leading to death were identified in 81/112 (72.3%) of the cases. Fifty-seven of
these (70.4%) were identified by the MIA. No active malaria was identified, and PCR analysis
for P. falciparum was negative in all cases, but four patients had histological evidence of previ-
ous malaria (hemozoin in liver macrophages). Three patients had liver schistosomiasis.
Discussion
This study shows that an easy, rapid, and non-disfiguring standardizedminimally invasive
sampling procedure designed for postmortem studies in Mozambique may provide a correct
diagnosis in the majority of cases. This validation study shows a high degree of concordance
(75.9%; kappa = 0.732) between the MIA and CDA diagnoses in a series of adults who died at a
quaternary hospital in Mozambique. These findings are important since they open a new path-
way for cause of death investigation in places where postmortemmethods have not tradition-
ally been used. This methodmay improve the current capacities to conduct cause of death
surveillance in large parts of the world where mortality remains high but knowledge of what
people die of is currently based on assumptions.
In this study, the concordance of the MIA diagnosis with the CDA diagnosis was almost
80% for infectious diseases. These results are similar to a few recent reports using similar
approaches in HIV-positive/AIDS patients [19,20]. The leading cause of infectious deaths in
the current study wasM. tuberculosis, a finding consistent with previous autopsy studies from
sub-Saharan Africa [19–22]. Interestingly, the MIA protocol consistently provided good qual-
ity tissues for adequate microbiological analyses, allowing confirmation of the pathological
results and etiological characterization of the microorganisms causing death in over 86% of the
cases. Furthermore, the microbiology analyses increased the level of confidence in the diagnosis
when the strength of the pathological findings was low. Although the number of cases is lim-
ited, the two gastrointestinal infections identified as the cause of death by the CDAs were not
identified by the MIAs. Sampling of stool and/or bowel mucosa could be included in the proto-
col in order to improve these results [12,13]. However, further studies are necessary to evaluate
the usefulness of stool analysis in postmortem studies. Additionally, the MIA was relatively less
efficient for the diagnosis of pulmonary infections, which were missed in 29.2% of the cases,
reflecting the relatively lower efficiencyof the needle sampling for the lung [12,13].
The MIA diagnosis was also highly accurate for malignant tumors, especially for hepatocel-
lular carcinoma and Kaposi sarcoma, two of the most prevalent tumors in Mozambique
according to a recent report [23]. Identification of other non-infectious diseases (including
Table 5. Correlation between the minimally invasive autopsy diagnosis and the complete diagnostic autopsy diagnosis of all cases, grouped
according to the major disease categories.
Minimally Invasive Autopsy Complete Diagnostic Autopsy Total
Infection Tumor Other Non-conclusive
Infection 72 0 1 0 73
Tumor 0 13 0 0 13
Other 2 0 12 0 14
Non-conclusive 6 3 3 0 12
Total 80 16 16 0 112
doi:10.1371/journal.pmed.1002171.t005
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cardiovascular, lung, gastrointestinal, and kidney diseases) was less accurate using the MIA
procedure. Diagnosis of such entities, however, remains challenging even with the CDA due to
the variety of lesions and organs involved. These cases often require a combination of all the
macroscopic data available and frequently the clinical information, which was not used in our
study, to complete the non-conclusive pathological results [24–26].
Innovative strategies have been developed to overcome the low acceptability and feasibility
of the CDA. Ideally, these alternative postmortem examination methods should be capable of
providing results comparable to conventional CDA. Imaging-basedmethods using magnetic
resonance imaging, computerized scans, or ultrasounds, frequently combined with needle
biopsies, have been all shown to provide accurate results [27,28]. However, costs, reliance on
sophisticated equipment, and mandatory involvement of highly skilled personnel are critical
limitations of these strategies that hamper their introduction in low-income settings [29]. In
recent years, different approaches based only on minimally invasive tissue sampling [30–32]
have been proposed as potential substitutes for CDA. This MIA is expected to be more accept-
able to the relatives of the deceased person than the CDA, especially in rural areas, where most
deaths still occur in low-income countries [33]. In addition, the MIA procedure likely involves
less risk than the CDA for health personnel, something of critical importance when faced with
highly contagious infectious diseases. Finally, the MIA procedure could easily be performed by
trained technicians, which might enable widespread use of this method in low-income coun-
tries in the absence of a sufficient pathologist workforce.
A possible limitation of theMIA is that its diagnostic accuracymay be influenced by the dis-
semination of the disease: the performance of the procedure may be significantly reduced in
focal lesions and in limited infections in immunocompetent hosts. In this study, more than
half of the patients were HIV-infected adults with disseminated infections, which might have
increased the diagnostic yield of the MIA. Additionally, the study population included only
hospitalized patients, whose causes of death may not reflect accurately the predominant causes
of death occurring in the community. A limitation for its potential use in rural areas is that
recruitment of cases into the study was restricted to the first 24 h after death. Given that a sig-
nificant proportion of deaths in low-income countries occur at home, it is plausible that access
to those bodies could possibly be delayed beyond the first 24 h, which may affect the perfor-
mance of the MIA. Both theMIA and the CDA include a degree of expert subjective interpreta-
tion. In the present study, both evaluations were made by the same group of experts in order to
focus on the differences between the two methods, thus minimizing the differences in expertise
between observers.As a consequence, the study design can support internal consistency, but
not necessarily external generalizability, particularly given the subjective nature of the histolog-
ical interpretation. Finally, limited experience in pathology (histochemistry, immunohis-
tochemistry) and microbiology (molecular diagnostics) laboratories and restricted resources
may be a limitation for both CDA and MIA implementation in low-income settings.
In conclusion, the results of this study confirm that the MIA procedure is a valid tool com-
parable to the gold standard, CDA, for cause of death determination in adult deaths in Mozam-
bique. This method could have an important role in determining the cause of death in middle-
and low-income countries where accurate assessment of the causes of mortality is virtually
nonexistent and where infectious diseases are extremely frequent. The diagnostic accuracy of
the MIA for cause of death determination needs to be assessed also in specific vulnerable
groups, including in pediatric and maternal deaths. The use of this tool could improve health
planning and priority setting and, ultimately, improve the duration of healthy lives for the
most vulnerable populations in the world.
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S1 Table. Diagnoses obtained by complete diagnostic autopsy (final diagnosis) and mini-
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putative diagnoses), the underlying conditions and other significant conditions, and the ICD-
10 codes are shown. The level of certainty of the putative and final diagnoses as well as the
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